## ACGL: Arch Capital Group Ltd. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 2.8% below STRENGTH zone (3.0-6.0%); PEG 2.24 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($90.76)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Slower Premium Growth but Strong Margins in Q3 2025 Could Be A Game Changer For Arch Capital Group (ACGL)**
- Source: Simply Wall Street | 20251212T022758 | Somewhat-Bullish | Relevance: 100%
- Arch Capital Group (ACGL) reported mixed Q3 2025 results, with a revenue decline and written premium growth below expectations due to slower markets. Despite this, the company maintained strong underwriting margins, growing net investment income, and solid return on equity. The investment narrative for ACGL hinges on its ability to sustain these strong margins and disciplined underwriting to offset softer premium growth in mortgage and reinsurance.

**2. Slower Premium Growth but Strong Margins in Q3 2025 Could Be A Game Changer For Arch Capital Group (ACGL)**
- Source: Simply Wall Street | 20251212T020751 | Somewhat-Bullish | Relevance: 100%
- Arch Capital Group recently reported mixed Q3 2025 results, with a revenue decline due to slower premium growth in mortgage and reinsurance. Despite top-line pressures, strong underwriting margins, growing net investment income, and solid return on equity are highlighted as key strengths. The company's future investment narrative will likely depend on how well these strengths offset the slower premium growth.

**3. Arch Capital Group Ltd. Stock Outperforms Competitors On Strong Trading Day**
- Source: 富途牛牛 | 20251210T090729 | Bullish | Relevance: 100%
- Arch Capital Group Ltd. (ACGL) saw its stock price increase by 2.04% on a strong trading day, outperforming competitors. The article briefly mentions Unity Software's (U.US) Q4 earnings, which showed a 35% year-over-year revenue increase to $609 million, beating estimates, despite reporting a quarterly loss of 66 cents per share. This financial update from Unity Software is presented alongside the performance of Arch Capital Group.

**4. Arch Capital Group (ACGL): Reassessing Valuation After Mixed Q3 Results and Cooling Growth Expectations**
- Source: Simply Wall Street | 20251215T130811 | Somewhat-Bullish | Relevance: 100%
- After mixed Q3 results showing softer growth in written premiums and cooling demand in mortgage and reinsurance, analysts are reassessing Arch Capital Group's (ACGL) valuation. The company is currently trading at a mid-single-digit discount to analyst targets, with a fair value estimate significantly above its recent close. While near-term optimism is building, longer-term expectations remain tempered due to these trends.

**5. Squarepoint Ops LLC Sells 101,208 Shares of Arch Capital Group Ltd. $ACGL**
- Source: MarketBeat | 20251214T140713 | Neutral | Relevance: 100%
- Squarepoint Ops LLC reduced its stake in Arch Capital Group Ltd. (NASDAQ:ACGL) by 52.5%, selling 101,208 shares and retaining 91,525 shares valued at approximately $8.33 million. This comes as other institutional investors, including Norges Bank, Ameriprise Financial Inc., Champlain Investment Partners LLC, Worldquant Millennium Advisors LLC, and Man Group plc, significantly increased their positions in the company. Despite Arch Capital beating quarterly earnings and revenue estimates, analysts maintain a consensus "Hold" rating with a target price of $106.85.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Roth Capital | $110 | $125 | -12% |
| 2025-11-17 | Morgan Stanley | $110 | $105 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Roth Capital | main | Buy |
| 2025-11-17 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($1.62M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 7 |

**Top Holders:**
- Vanguard Group Inc: 11.7% (-0.2%)
- Blackrock Inc.: 8.9% (-1.4%)
- Artisan Partners Lim: 6.5% (-0.8%)
- BAMCO Inc.: 5.2% (-4.9%)
- State Street Corpora: 4.6% (-1.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +5.7% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.24 elevated, pricing in significant growth expectations. Forward P/E 10.2x stretched relative to 0% growth. Quality metrics strong (margin 21%). Balance sheet: strong liquidity (7513000000.0x), $2.2B free cash flow. Insider selling cluster ($1.6M in 90 days), potential headwind. Institutional flow bullish (3 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.1B |
| Beta | 0.45 |
| 52W Range | $82.45 - $97.40 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.24 |
| Forward P/E | 10.2 |
| Current P/E | 10.2 |
| YoY Growth | 0.4% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -2.9% to 2.8% (+5.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.2pp (needs >3.0% for momentum thesis). MRS_5 at 3.0% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -SLH (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.79% (CS: 62) | Neutral |
| RSI_14 | 61.7 | Neutral |
| MACD Histogram | -0.05 | Bearish |
| vs SMA20 | 1.015x | Above |
| vs SMA50 | 1.039x | Above |
| vs SMA200 | 1.032x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $93.92
- **Stop Loss:** $90.76 (3.4% risk)
- **Target:** $97.08 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 379
- **Position Value:** $35,595.68
- **Portfolio %:** 35.60%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-10 (Est: $2.33)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.25 | $2.77 | +22.9% |
| 2025Q2 | $2.30 | $2.58 | +12.2% |
| 2025Q1 | $1.31 | $1.54 | +17.2% |
| 2024Q4 | $1.80 | $2.26 | +25.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*